Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/17/2013 | WO2012149454A3 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use |
01/17/2013 | WO2012149376A3 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same |
01/17/2013 | WO2012139097A3 Method of inducing neutralizing antibodies to human immunodeficiency virus |
01/17/2013 | WO2012104025A3 Balneotherapeutic lipid-containing probiotic preparations and their applications |
01/17/2013 | WO2012082950A3 Chimeric fibronectin matrix mimetics and uses thereof |
01/17/2013 | US20130018112 Cellulose nanoparticle aerogels, hydrogels and organogels |
01/17/2013 | US20130018111 Biodegradable and biocompatible shape memory polymers |
01/17/2013 | US20130018110 Hydrogel synthesis |
01/17/2013 | US20130018085 iRNA Agents Targeting VEGF |
01/17/2013 | US20130018078 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
01/17/2013 | US20130017264 Alginate tube drug delivery system and method therefor |
01/17/2013 | US20130017235 Orally administered agent and an orally administered agent/supporting substrate complex |
01/17/2013 | US20130017232 Synthetic bone grafts |
01/17/2013 | US20130017230 Jelly-form preparation and method for producing jelly-form preparation |
01/17/2013 | US20130017227 Wound healing compositions and associated methods |
01/17/2013 | US20130017223 Methods and compositions for delivery of nucleic acids |
01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
01/17/2013 | US20130017184 Stabilised solid compositions of factor VII polypeptides |
01/17/2013 | US20130017177 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof |
01/17/2013 | CA2878701A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
01/17/2013 | CA2841864A1 Novel anti-cancer isocarbostyril alkaloid conjugates |
01/17/2013 | CA2841632A1 Gel compositions of oxymetazoline and methods of use |
01/17/2013 | CA2841445A1 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
01/17/2013 | CA2840460A1 Antibodies that bind to ox40 and their uses |
01/16/2013 | EP2546342A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
01/16/2013 | EP2545940A1 Parenteral compositions |
01/16/2013 | EP2545912A1 Ketoprofen-containing aqueous adhesive skin patch |
01/16/2013 | EP2545904A1 Jelly-form preparation and method for producing jelly-form preparation |
01/16/2013 | EP2545100A2 A biodegradable polymeric hydrogel composition |
01/16/2013 | EP2545089A1 Graft copolymer with ph dependent behaviour |
01/16/2013 | EP2545065A2 Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof |
01/16/2013 | EP2544768A1 Anti-cancer agent delivery vehicles capable of improved laoding |
01/16/2013 | EP2544721A1 Non-aqueous high concentration reduced viscosity suspension formulations |
01/16/2013 | EP2544720A1 Carbohydrate-polyamino acid-drug conjugates |
01/16/2013 | EP2544695A1 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
01/16/2013 | EP2544689A2 Solid compositions |
01/16/2013 | EP2544663A2 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
01/16/2013 | EP2544662A2 Foamable formulation |
01/16/2013 | EP2544661A2 Micelle compositions and process for the preparation thereof |
01/16/2013 | EP2544658A2 Injectable drug delivery system |
01/16/2013 | EP2544657A2 The use of amisulpride as an anti-emetic |
01/16/2013 | EP2544537A1 Parenteral formulations of macrolide antibiotics |
01/16/2013 | EP2544536A1 Fatty acid conjugates of quetiapine, process for making and using the same |
01/16/2013 | EP2014304B1 Colon cleansing compositions |
01/16/2013 | CN1954073B Modified Bouganin proteins, cytotoxins and methods and uses thereof |
01/16/2013 | CN1925867B Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
01/16/2013 | CN102884181A Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
01/16/2013 | CN102884041A Cationic lipid |
01/16/2013 | CN102883750A 选择性整联蛋白抑制剂 Selective integrin inhibitors |
01/16/2013 | CN102883746A Cancer treatment |
01/16/2013 | CN102883735A Transdermal administration of peptides |
01/16/2013 | CN102883725A Topical pharmaceutical compositions comprising mometasone furoate |
01/16/2013 | CN102883715A Chitosan-containing protective composition |
01/16/2013 | CN102883714A Indigestible polymer: starch acetate-based film coatings for colon targeting |
01/16/2013 | CN102883710A Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same |
01/16/2013 | CN102876681A Nucleic acid aptamer for targeted medicament carrier |
01/16/2013 | CN102875848A Biological composite material and capsule prepared from biological composite material |
01/16/2013 | CN102875818A Polyamino acid grafted copolymer and preparation method thereof |
01/16/2013 | CN102875790A Polyether random copolymer and preparation method thereof |
01/16/2013 | CN102875789A Polyether block copolymer and preparation method thereof |
01/16/2013 | CN102875772A Polyurethane block copolymer, preparation method thereof and preparation method of polyurethane block copolymer nano hydrogel |
01/16/2013 | CN102875695A Glutathione sensitive alkylated chitosan and preparation and application thereof |
01/16/2013 | CN102875684A FGFR single-stranded antibody fusion protein and application thereof in preparing targeting tumor cells medicines |
01/16/2013 | CN102875675A Anti-human serum albumin single-chain antibody and method for connecting polypeptide medicine with nitrogen terminal of antibody |
01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
01/16/2013 | CN102874782A Preparation of low-crystalline nano hydroxyapatite through membrane modulation and mineralization method |
01/16/2013 | CN102872463A Nanoparticles comprising rna ligands |
01/16/2013 | CN102872462A Ambroxol hydrochloride composition and preparation thereof |
01/16/2013 | CN102872458A Therapeutic vaccine adjuvant |
01/16/2013 | CN102872451A Liquid composition of factor vii polypeptides |
01/16/2013 | CN102872450A Composition for composite drug administration |
01/16/2013 | CN102872354A Application of composition Xiaoke pills in preparation of information intervention agent, preparation method of information intervention body and product |
01/16/2013 | CN102872295A New process for preparing cinnamon, Radix aconiti lateralis preparata and rehmannia root preparation |
01/16/2013 | CN102872251A Syrup for relieving cough and eliminating phlegm and preparation method thereof |
01/16/2013 | CN102872246A Medicine for treating cervical erosion through HPV (human papillomavirus) positive-to-negative change and preparation method of medicine |
01/16/2013 | CN102872234A Qingkailing and bupleurum orally disintegrating tablets for animals and preparation method thereof |
01/16/2013 | CN102872173A Compound acetaminophen orally disintegrating tablet for beasts and birds and preparation method for compound acetaminophen orally disintegrating tablet |
01/16/2013 | CN102872159A Nano-silver chitosan gel foam preparation for treating vaginal bacterial inflammation, and preparation method thereof |
01/16/2013 | CN102872158A External drug combination for curing eczema and preparation method thereof |
01/16/2013 | CN102872156A Lubricant containing hyaluronic acid |
01/16/2013 | CN102872061A Composition of creatine phosphate and arginine |
01/16/2013 | CN102872021A Medicinal composition containing ceftezole sodium compound and preparation method for medicinal composition |
01/16/2013 | CN102872019A Efavirenz preparation adopting micronization technology |
01/16/2013 | CN102872013A Anti-parasitic disease compound Triclabendazole granule for flocks and herds and preparation method for anti-parasitic disease compound Triclabendazole granule |
01/16/2013 | CN102872002A Hydroxysafflor yellow A oil solution and preparation method and application thereof |
01/16/2013 | CN102871997A Controlled-release medicinal composition containing demethyl venlafaxine benzoate compounds |
01/16/2013 | CN102871994A Flurbiprofen acetaminophen ester cyclodextrin inclusion compound and preparation method thereof |
01/16/2013 | CN102871988A Jelly-form preparation and method for producing jelly-form preparation |
01/16/2013 | CN102871985A Hemoglobin microcapsule blood substitute and its preparation method |
01/16/2013 | CN102871984A Phenylephrine hydrochloride oral instant membrane and preparation method thereof |
01/16/2013 | CN102871979A Slow release pharmaceutical preparation and method of administering same |
01/16/2013 | CN102871978A Levosulpiride tablets and preparation method thereof |
01/16/2013 | CN102871977A Ulipristal acetate dispersible tablet and preparation method thereof |
01/16/2013 | CN102871976A Tablet containing roflumilast as active ingredients and preparation method of tablet |
01/16/2013 | CN102871973A Omeprazole sodium freeze-drying preparation and preparation method thereof |
01/16/2013 | CN102871972A Lyophilized lansoprazole preparation and preparation method thereof |
01/16/2013 | CN102871971A Freeze-dried powder injection of vitamin B6 and preparation method thereof |
01/16/2013 | CN102871970A Puerarin oral adhesion microballoon spheres and preparation method thereof |
01/16/2013 | CN102871969A Application of erythropoietin microspheres to preparation of drugs for treating motor complications in Parkinson's disease |
01/16/2013 | CN102871968A Preparation method for sildenafil rhubarb hydrochloric acid salt medicine granules and preparation method for suction type aerosol of gradules |